Alterome Therapeutics
Alterome Therapeutics is a biopharmaceutical company developing next-generation, small molecule targeted therapies for cancer treatment. They utilize a structure-guided machine learning approach (Kraken platform) to create precision therapies targeting specific cancer-causing mutations, enhancing safety and efficacy. Their pipeline includes inhibitors targeting AKT1 E17K and KRAS mutations.
Buy Funded Startups lists
Funding Round: Series B
Funding Amount: $132M
Date: 03-Apr-2024
Investors: Goldman Sachs Alternatives, Canaan Partners, Driehaus Capital Management, Invus, Digitalis Ventures, Blue Owl Capital, Orbimed, Nextech Invest, Vida Ventures, Boxer Capital, Colt Ventures
Markets: Biotechnology, Oncology, Precision Medicine
HQ: San Diego, California, United States
Founded: 2021
Website: https://www.alterome.com
LinkedIn: https://www.linkedin.com/company/alterome/
Twitter: https://twitter.com/AlteromeTx
Crunchbase: https://www.crunchbase.com/organization/alterome-therapeutics
Leave a Comment
Comments
No comments yet.